Epilepsy, a common childhood condition, is largely managed by general paediatricians. To assess whether recent management guidelines are being met, we undertook a prospective questionnaire-based survey of children with epilepsy, attending the general paediatric out-patient clinic, at the Royal Liverpool Children's Hospital, Alder Hey. Ninety-one children were identified over seven months--giving a prevalence of epilepsy in this out-patient population of 13.7/1000. Fifty-four per cent were diagnosed as having tonic-clonic, 16% partial and 5% typical absence seizures. Forty-two per cent received carbamazepine and 33% sodium valproate, as monotherapy, and 7% were treated with multiple antiepileptic drugs (AEDs).
INTRODUCTION
Epilepsy is the most common neurological disorder of childhood; approximately 50000-100 000 children in the UK have epilepsy and for many it is a chronic, even life-long condition. The vast majority of epilepsy in children is managed by general paediatricians who may or may not have a specific interest in epilepsy and specialist advice is not always available due to the limited number of paediatric neurologists. Recently published guidelines have recommended basic standards of epilepsy care and management ~. Ideally, these standards should be met wherever and whenever children with epilepsy are seen, irrespective of the level or degree of hospital specialization.
With some of these standards in mind we undertook a prospective survey of children with epilepsy attending the out-patient department of a large children's hosptiai. The results of this survey have demonstrated the need for providing local written guidelines regarding the importance of seizure and epilepsy syndrome identification and the appropriate use of antiepileptic drugs, monitoring and specialist referral. These guidelines should, in turn, improve epilepsy management and enable the basic standards of care to be met.
PATIENTS" AND METHODS
The study was undertaken in the out-patient department at the Royal Liverpool Children's Hospital (Alder Hey), and was questionnairebased. Questionnaires were placed in each clinic room in the paediatric out-patient department, and were completed by the 10 general paediatric consultants who supervised the clinics. Children attending the specific epilepsy and neurology clinics run by the the two consultant paediatric neurologists were excluded from the study.
Information was collected on the following: date of birth and age at onset of seizures: type of seizure: classification of epilepsy type or syndrome: frequency of seizures: antiepileptic medication; frequency of clinical reviews: consultation with a paediatric neurologist: routine measurement of anti-convulsant levels: and method of follow-up including discharge. The uses (appropriate or otherwise) of the electroencephalogram (EEG) and neuro-imaging were not assessed in this particular study.
The study took place over a seven month period, from 1 November 1992 to 31 May 1993. This period was chosen in an attempt to identify most of the children attending clinic regularly over as short a time as possible to encourage cooperation with the study; whilst it should have detected most children on six-monthly reviews, the study may have missed a number with annual appointments. However, it is likely that this would have constituted only a very small proportion of the total out-patient population with epilepsy.
Information was also obtained on the total number of children attending the general clinics over the same period to ascertain the prevalence of epilepsy in this paediatric out-patient population.
RESULTS
Ninety-eight questionnaires were completed over the seven month period; seven of these 98 patients had only experienced one seizure and were therefore excluded. Ninety-one children had experienced at least two or three epileptic seizures; these 91 patients therefore comprised the study population. The total number of children seen in general paediatric out-patient clinics during the same period was 6 925 giving a prevalence of 13.7/1 000 of children with epilepsy attending the general out-patient department.
Diagnosis of seizure type
Forty-nine children (54%) were diagnosed as having primary (idiopathic) generalized tonicclonic seizures, 11 (12%) complex partial seizures, five primary generalized absence seizures, four myoclonic seizures and four simple partial seizures. The precise seizure type was unclear in seven children (8%). The remaining 11 children were diagnosed as having multiple seizure types (Fig. 1 ).
Frequency of use of different antiepileptic drugs
Carbamazepine (CBZ) was used as monotherapy in 42% of children and sodium valproate (VPA) in 33%. Phenytoin was used in isolation in 4% of children and 14% were on no medication at the time of the study. The remaining 7% of children were receiving a combination of two or three antiepileptic drugs (Fig. 2) .
Correlation between antiepileptic drugs and seizure types
Nineteen (39%) of the 49 children with primary generalized tonic-clonic seizures were treated with CBZ, 18 with VPA and one with a combination of these. Three received phenytoin and eight were on no medication. Ten children with complex partial seizures were treated with CBZ (one in combination with phenytoin and vigabatrin) and all four children with simple partial seizures received CBZ. Three of the four children with myoclonic seizures were taking VPA, the remaining child was receiving no treatment. Eight children with absence seizures, with or without tonic-clonic seizures, were prescribed VPA, three were treated with CBZ and the remaining child received VPA and CBZ (Table 1 ) . 
Seizure type

Routine antiepileptic drug (AED) levels
Twenty-seven children out of a total of 78 treated with antiepileptic drugs (35%) had drug levels measured routinely. This comprised 18 of the 38 children on CBZ (47%), five of 30 on VPA (17%), three of the four children on CBZ and VPA polytherapy (75%), and the one child on triple therapy with CBZ, phenytoin and vigabatrin. None of the four children on phenytoin monotherapy underwent routine drug monitoring. On closer analysis of these results two of the twenty-seven children undergoing routine AED level monitoring experienced weekly seizures (7%), seven had monthly seizures (26%), nine, three to six monthly seizures (33%), five, six to 12 monthly seizures (19%), and four had experienced no seizures in the previous 12 months (15%) (Fig. 3) .
It should be noted that the practices of individual consultants influenced these results; e.g. one of the 10 consultants appeared to follow a policy of regular AED monitoring, measuring blood levels on 17 out of the 24 under his care (70%). If these children are excluded, then only 10 of the remaining 54 children (19%) had routine blood level monitoring of antiepileptic therapy.
Frequency of seizures
Seizures occurred most commonly at six to 12 monthly intervals (26%) and three to six monthly intervals (25%). Thirty-one per cent were experiencing at least one seizure each month (5% daily, 5% weekly and 20% monthly). Sixteen per per cent of children had experienced no seizures in the preceding year (Fig. 4) .
Frequency of clinic visits
The majority of the children (82%) were attending clinic every two to six months, 8% attended every two to four weeks and 7% attended annually (Fig. 5 ).
Correlation between frequency of seizures and frequency of clinic visits
All five children experiencing daily seizures were seen at least every two to three months. However, one of the five children with weekly seizures was being seen only every six months. The majority of children were seen at two, three, or six monthly intervals and most of these were experiencing seizures every three to 12 months. One child had been discharged back to the general practitioner, having had no seizures in the previous 12 months--this child's CBZ was discontinued on the day of discharge. The one child discharged to the community paediatrician had also experienced no seizures in the previous 12 months and was being weaned off CBZ (Table 2) . Correlation between frequency of seizures and paediatric neurology referrals
One of the five children with daily, two of the five children with weekly, and three of the 18 with monthly seizures were referred for a paediatric neurology opinion. In total, 14% of children were referred for a neurological opinion (Fig. 6 ).
DISCUSSION
The prevalence of epilepsy in our paediatric out-patient department is 13.7/1 000. This figure lies between previously reported rates -''3'4, and is higher than a recent UK study 5. This may reflect patient selection following referral to the outpatient department. It is also possible that some of the patients with epilepsy may have been incorrectly diagnosed as no attempt was made to verify the diagnosis. Finally, some patients on annual review may not have been identified as the study was not undertaken over a 12 month period: however it is unlikely that this would have been a large number or would have significantly affected the prevalence, or the overall results and conclusions of the study.
As with the diagnosis of epilepsy, no attempt was made to confirm the diagnosis of specific seizure types and syndromes: the data were based simply on the individual clinician's assessment of the child's seizures. This may, therefore, have influenced the classification of seizures/epilepsies within our study population. In addition, it must be stressed that many (if not most) of the children with partial and symptomatic generalized seizures/epilepsies would have been attending the specialist neurology/epilepsy clinics and would therefore be under-represented in this survey. With these caveats in mind a diagnosis of primary generalized tonic-clonic seizures/ epilepsy was made in 56% of cases, in contrast to an "accepted" frequency of 5-10%. Typical absence epilepsy was diagnosed in 6% of children and a further 5% in association with tonic-clonic seizures in our population; this is in contrast to a reported frequency of 8%. Three children (3%) were diagnosed as having juvenile myoclonic epilepsy, which is in closer agreement, with a reported rate of 5%. Partial seizures are considered to comprise up to 40% of childhood epilepsy. In our study, the figure was 18%, of which 14% were complex partial (against the anticipated 25%), and 4% simple partial. Of particular interest was the infrequent use of epilepsy syndromes in classification. Only two 
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Frequency of seizures children (2%) were diagnosed as having benign rolandic epilepsy of childhood, which is believed to comprise between 15 and 20% of childhood epilepsy. No cases of Lennox-Gestaut syndrome were diagnosed despite the fact that this syndrome is felt to constitute approximately 10% of all childhood epilepsy; one explanation for this is that any patient with this syndrome was more likely to be attending the specialist neurology/epilepsy clinics.
With regard to treatment, CBZ was the most frequently prescribed antiepileptic drug and it was reassuring to note that only 7% of children were receiving more than one AED. However, it was surprising to find that CBZ was the most commonly used drug in the treatment of primary generalized tonic-clonic epilepsy, which is contrary to the currently accepted recommendation of VPA 6. The majority of children (73%) with absence epilepsy were appropriately prescribed VPA, whilst the remainder were prescribed CBZ.
All the children with a diagnosis of partial (simple or complex) seizures/epilepsy were treated with CBZ. Only one child in the study was receiving one of the new AEDs (vigabatrin); this was not unexpected as it is likely that most of the children receiving the newer drugs would be attending specialist paediatric neurology clinics. The appropriateness of routine AED level monitoring in children with epilepsy remains a problem. There are very few true indications for such investigations and it is clear from this study that guidelines are not being followed. In 35% of these children it was deemed necessary to monitor AED levels. This is clearly an unacceptable level of intervention. Whilst we cannot comment on individual circumstances, we do have some additional information regarding these patients. One-third were experiencing at least monthly seizures, and presumably underwent AED level monitoring because of poor control, and perhaps with concerns about noncompliance. One would hope that the process of optimising drug dosage would be pursued prior to assessing blood levels in this circumstance. Fifty per cent were experiencing three to 12 monthly seizures and 15% had had no seizures in the previous 12 months, and yet still quite inappropriately underwent "routine" AED level monitoring. Guidelines quite clearly indicate that suspicion of major non-compliance is one of the only true indications for measuring AED levels. Where seizure control remains unacceptable despite confidence in compliance, and assuming an adequate AED regime with appropriate weight-adjusted doses, referral to a paediatric neurologist would be preferable to unnecessary investigations. The only other situations in which AED levels should be measured are those of status epilepticus and AED polytherapy--in particular when drug interactions which may alter AED levels are known and anticipated, but again, only where seizure control remains suboptimal.
When correlating frequency of seizures with frequency of clinic visits, the results were largely as expected, with children experiencing frequent seizures attending clinic most often. Children experiencing daily seizures were all seen at least every two to three months. Whilst we do not have all the clinical information on these patients, one could reasonably have anticipated more frequent reviews in an attempt to not only improve seizure control but to discuss the broader issues of care and management. In contrast, 12 children who had been seizure-free in the previous 12 months were still being reviewed every six months, when perhaps annual reviews would have been equally acceptable and satisfactory. One child was discharged to the general practitioner, the other to a community paediatrician; this seemed entirely appropriate as both children had been seizurefree for over two years and the antiepileptic drugs were being withdrawn at the time of discharge.
The question of when patients with epilepsy should be discharged from a hospital clinic to the general practitioner or, as is common in paediatrics, to a community paediatrician, is unclear, frequently controversal and is clearly influenced by the individual circumstances. It is our belief that children receiving antiepileptic medication, irrespective of seizure frequency, should remain under hospital review until either the medication can be successfully withdrawn or the 'child' can be transferred to an adult neurology/epilepsy clinic. This is primarily to allow a continuity of specialist epilepsy care and to permit a wellinformed decision about stopping treatment as many of the childhood epilepsies remit before puberty. The findings of our survey would suggest that at least in this hospital, the paediatricians share this belief.
Fourteen per cent of children with a diagnosis of epilepsy were referred for a neurological opinion. It could have been reasonably expected that the 28 children (31%) with poor seizure control (seizures occurring daily, weekly or monthly) would have been referred but this was not the case, three of the five children with weekly and 15 of the 18 children experiencing monthly seizures were managed solely by a general paediatrician. None of the eight children with unclassified seizures, five of whom were experiencing seizures at least once a month, were referred to a paediatric neurologist. These are the children (and families) who are in most need of specialist review, principally for advice on specific drug treatment, but also to discuss the broader issues of further investigation, prognosis and epilepsy management.
CONCLUSION
This survey suffers from a number of methodological limitations or difficulties; it is questionnairebased, was undertaken over a relatively short period of time and no attempt has been made to confirm the diagnosis of either epilepsy or the seizure type and epilepsy syndrome. Despite these inadequacies the survey has identified a number of points, many of which highlight the need to educate (and support) those clinicians who manage children with epilepsy.
1. Epilepsy is a common disorder encountered in a paediatric out-patient department (13.7/1000 in our population). Even if a false diagnosis rate of 10-20% is assumed 7"~, the prevalence in our study group would still be 11/1000, or over 1%. 2. The frequency of the different seizure types and epilepsy syndromes identified in this study suggest that the classification of the epilepsies 9'~° is perhaps poorly understood and applied amongst general paediatricians. 3. The most commonly prescribed AEDs, were CBZ and VPA, currently the universally recommended drugs of first choice. However the correlation of seizure type and AED was frequently inappropriate; this has important practical implications in that some patients' epilepsy may be falsely labelled as being 'intractable' or drug-resistant because the wrong drug tias been prescribed for the epilepsy/epilepsy syndrome.
It is clear that the most common inappropriate AED-epilepsy combination was the use of carbamazepine in primary generalized tonic-clonic epilepsy (including juvenile myoclonic epilepsy). This same phenomenon may also explain why a number of patients were receiving two or three AEDs. The 'routine' measurement of AED levels was undertaken too frequently and almost certainly without a definite clinical indication. Too few children were referred to either of the two paediatric neurologists for a specialist epilepsy opinion. It is clear that general paediatricians should have a lower threshold for requesting specialist advice, particularly in children in whom the seizure type(s) is (are) difficult to classify or if seizures are frequent and are resistant to a single drug. Conversely it is equally important that there is an adequate availability of paediatric neurologists to provide this advice. In this study it was reassuring to find that the vast majority of children with epilepsy receiving an AED remained under the care of the paediatrician, irrespective of seizure frequency. 
